Synthimed Labs

synthimed.com · San Diego, United States of America

Synthimed Labs is a biotechnology company focused on developing synthetic biology and biomaterials solutions for medical and life science applications. It appears to work on research-driven products and services for healthcare and scientific customers, though detailed public information about its commercial offerings is limited.

Revenue
$1.5M
Employees
15
Founded
2019
Headquarters
San Diego, United States of America

What 17 Arbolus experts think of Synthimed Labs

Synthimed receives strong NPS scores (8-10) from the majority of experts, especially those with over a year of engagement and higher annual spend. Renewal intent is high, with nearly all respondents (except one 'Not Sure') indicating plans to continue, especially among Influencers and business leads. Stickiness is reinforced by multi-year contracts and reports of flexibility in engagement. Key feedback highlights include praise for cost-value balance, reliable chemistry execution, and fast turnaround, balanced by constructive criticism regarding limitations in integrated biology-discovery services and scalability for major portfolio expansions.Overall Customer Sentiment: Positive

Who reviewed Synthimed Labs

Total customers 17 15 current · 2 former
Reviews growth +6 in six months
Seniority of respondents
  • C-Suite 71% (12)
  • Director 24% (4)
  • Manager 6% (1)
Revenue Leader C-Suite NPS 8 Will renew
Operations Manager C-Suite NPS 9 Will renew
Operations Leader Director NPS 9 Undecided

Employer names and spend open in the full report, along with the other 14 customers.

Everything 17 customers told us about Synthimed Labs.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Open the full report

Sentiment

52 Net Promoter Score, from 17 scored reviews
  • Promoters 10
  • Passives 6
  • Detractors 1

Cumulative NPS by month

+0 over 5 months
  • Oct 9
  • Feb 8
  • Mar 8
  • Jul 9
  • Aug 9

Net Promoter Score across 2 reviews, accumulated up to each month. Category median 42 across 2 companies.

Praised

  • Reliable Execution for Mid-Complexity Chemistry
  • Flexibility and Responsiveness
  • Strong Cost to Value Balance
  • Expansion into AI-Assisted and Integrated Platform Services

Criticised

  • Compliance and Data Security Concerns
  • Reliability and Execution Gaps
  • Pricing and Cost Competition
  • Consistency Post-Acquisition Needs to Be Proven

What customers say

Reliable Execution for Mid-Complexity Chemistry
“I find their execution for mid-complexity chemistry projects reliable, offering consistent delivery and problem-solving when synthesis routes fail.”
Flexibility and Responsiveness
“I value the fast turnaround, direct scientist-to-scientist interaction, and flexible engagement model—easier to ramp FTE support than with rigid, large CROs.”
Strong Cost to Value Balance
“I appreciate their cost-effectiveness compared to large CROs, with efficient productivity that supports sustained medicinal chemistry work.”

Renewal intent

Plan to renew 75%
  • Will renew 12
  • Undecided 4
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 73% 11 answers
  • Director 75% 4 answers
  • Manager 100% 1 answer
  • 8.7/10 Average score from customers who will renew
  • 8.5/10 Average score from undecided customers

Top alternatives

Most weighed by Synthimed Labs customers

Report

For people who use Synthimed Labs

Do you use Synthimed Labs at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 17 customers of Synthimed Labs have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.